Skip to main content
CHEIL BIO CO., LTD. logo

CHEIL BIO CO., LTD. — Investor Relations & Filings

Ticker · 052670 ISIN · KR7052670007 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2022-04-13 Transaction in Own Shar…
Country KR South Korea
Listing KO 052670

About CHEIL BIO CO., LTD.

http://www.cheilbio.com/en/index.php

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from CheilBio regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). It includes a correction notice (정정신고) for the initial filing. Since the document details the company's decision to buy back its own shares through a trust, it falls under the 'Transaction in Own Shares' category.
2022-04-13 Korean
자기주식취득신탁계약체결결정
Transaction in Own Shares Classification · 100% confidence The document is a formal regulatory announcement regarding a company's decision to enter into a trust agreement for the acquisition of its own shares (share buyback). This is a specific corporate action related to treasury shares. According to the provided filing definitions, 'Transaction in Own Shares' (POS) is the correct category for reports of a company buying back or selling its own shares.
2022-04-12 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a structured summary of the resolutions passed during the meeting, including financial statement approval, dividend status, and board member appointments. This aligns perfectly with the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-03-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider trading or changes in share ownership by company directors and major shareholders. This corresponds directly to the 'Director's Dealing' category.
2022-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company Jeil Bio. It provides the audit opinion, key financial data, and details regarding the auditor (Hanmi Accounting Corp). While it contains financial data, it is a standard regulatory disclosure of the audit report submission rather than the full annual report (10-K) or a standalone audit report document. Given the structure and the nature of the filing as a regulatory announcement of the audit report, it falls under the category of Audit Report / Information. FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2021 (Jan 1, 2021 to Dec 31, 2021) for Cheilbio Co., Ltd. It contains detailed sections on company overview, history, capital changes, and business operations. In the context of South Korean regulatory filings, the '사업보고서' is the equivalent of the US 10-K Annual Report, providing full financial and operational disclosure for the fiscal year. FY 2021
2022-03-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.